LB
CRVO icon

Leo Brokerage’s CervoMed CRVO Stock Holding History

Leo Brokerage’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$6K Buy
+152
New +$6.33K ﹤0.01% 184

Other funds holding CRVO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
WSTAM
Wilbanks Smith & Thomas Asset Management Norfolk, Virginia $3.57B AUM 21.11% 1-Year Est. Return

Leo Brokerage's CRVO Position: Q3 2021 in Review

Leo Brokerage opened a new position in CervoMed (CRVO) in Q3 2021: 152 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #184 among its holdings.

24 funds tracked by Wall St. Rank hold CRVO as of Q3 2021.

  • Leo Brokerage held 152 shares of CervoMed worth $6K as of Q3 2021.
  • CervoMed was a new Leo Brokerage position in Q3 2021.
  • CervoMed made up ﹤0.01% of Leo Brokerage's portfolio in Q3 2021, its #184 holding.
  • 24 funds tracked by Wall St. Rank held CervoMed as of Q3 2021.

Based on Leo Brokerage's 13F filing for Q3 2021, filed 13 Oct 2021.